NCT06909097 is a NA clinical trial of Sitting breaks in Sedentary Employees, sponsored by Stanford University.

Who is sponsoring NCT06909097?

NCT06909097 is sponsored by Stanford University.

What drugs are being tested in NCT06909097?

Interventions in NCT06909097: Sitting breaks.

What condition does NCT06909097 study?

NCT06909097 studies Sedentary Employees.

Is NCT06909097 still recruiting?

NCT06909097 is currently recruiting now. Last updated 3 April 2025.

Last reviewed 2025-04-03 · How we verify

NCT06909097

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Better Breaks: Strength Breaks vs Walk Breaks for Sedentary Behavior Breaks

Recruiting now NA Last updated 3 April 2025

What this trial tests

NA trial testing Sitting breaks in Sedentary Employees in 40 participants. Currently enrolling.

Timeline

5 October 2024

Primary endpoint
1 December 2025

1 March 2026

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	40
Start date	5 October 2024
Primary completion	1 December 2025
Estimated completion	1 March 2026
Sites	1 location across United States

Drugs / interventions tested

Sitting breaks

Conditions studied

Sedentary Employees — all drugs for Sedentary Employees →

Sponsor

Stanford University

Who can join

30 and older, any sex, with Sedentary Employees. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the benefits of two different types of 2 minute activity breaks during sedentary workdays for people who sit for long periods of time in sedentary jobs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sedentary Employees

Currently open trials in the same condition.

NCT06780618 — The Effects of Brown Rice Compared to White Rice on Postprandial Changes in IL-6 and MDA Levels in Sedentary Workers · NA · recruiting

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06909097 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 3 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06909097.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing